Antibody therapy for rheumatoid arthritis.

High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...

Полное описание

Библиографические подробности
Главный автор: Taylor, P
Формат: Journal article
Язык:English
Опубликовано: 2003